Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$3.2 million.

  • Onconetix's Free Cash Flow fell 17766.12% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 4591.53%. This contributed to the annual value of -$10.5 million for FY2024, which is 4644.94% up from last year.
  • According to the latest figures from Q3 2025, Onconetix's Free Cash Flow is -$3.2 million, which was down 17766.12% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Free Cash Flow registered a high of -$925705.0 during Q4 2024, and its lowest value of -$7.9 million during Q2 2023.
  • For the 3-year period, Onconetix's Free Cash Flow averaged around -$3.3 million, with its median value being -$3.2 million (2025).
  • As far as peak fluctuations go, Onconetix's Free Cash Flow skyrocketed by 7853.13% in 2024, and later crashed by 17766.12% in 2025.
  • Onconetix's Free Cash Flow (Quarter) stood at -$4.3 million in 2023, then skyrocketed by 78.53% to -$925705.0 in 2024, then crashed by 244.6% to -$3.2 million in 2025.
  • Its Free Cash Flow was -$3.2 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$2.0 million in Q1 2025.